<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00224432</url>
  </required_header>
  <id_info>
    <org_study_id>METc/99/07/116</org_study_id>
    <nct_id>NCT00224432</nct_id>
  </id_info>
  <brief_title>Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis</brief_title>
  <official_title>Double-Blind, Parallel, Randomised Study to Investigate the Clinical and Immunological Effects of Oral Administration of Probiotic Bacteria in Infants With Atopic Dermatitis With and Without Cow’s Milk Allergy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groningen Research Institute for Asthma and COPD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Numico Research Wageningen, the Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groningen Research Institute for Asthma and COPD</source>
  <brief_summary>
    <textblock>
      To study the effect of supplementation of a hydrolyzed formula with probiotic bacteria on
      clinical and immunological parameters in infants with AD with and without CMA and to compare
      effectiveness of different strains of probiotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  To determine the effect of supplementation of a hydrolyzed formula with probiotic
           bacteria on clinical and immunological parameters in infants with AD with and without
           CMA

        -  To determine the effect of supplementation of a hydrolyzed formula with probiotic
           bacteria on clinical and immunological reactivity to cow’ milk challenge in infants with
           AD with CMA

        -  To compare the effectiveness of different strains of probiotic bacteria in improving
           clinical and immunological outcome in these infants
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2001</start_date>
  <completion_date>September 2002</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant decrease of SCORAD score in treated infants compared to placebo</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-4, IL-5 and IFN-gamma production of stimulated peripheral blood mononuclear cells</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in fecal TNF-α and α-1-antitrypsin, urinary EDN</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effect on faecal bacteria after probiotics</measure>
  </secondary_outcome>
  <enrollment>45</enrollment>
  <condition>Atopic Dermatitis</condition>
  <condition>Atopic Eczema</condition>
  <condition>Infantile Eczema</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>probiotics: Lactobacillus GG, lactobacillus Rhamnosus</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term infants fulfilling the Hanifin (1989) criteria for atopic dermatitis

               -  Suggestive of CMA (one additional symptom)

               -  Scorad index (total) &gt;20 at study entry

               -  Below 5 months of age

               -  Formula, not breast fed

               -  Written informed consent from the parents

        Exclusion Criteria:

          -  • Previous or current use of anti-histamines, oral corticosteroids, probiotics

               -  Use of systemic antibiotic or anti-mycotic drugs in the previous 4 weeks

               -  Congenital intestinal abnormality (eg. Hirschsprung’s disease, intestinal
                  atresia)

               -  Other GI disease with intestinal inflammation and/or increased intestinal
                  permeability

               -  Skin disorder, not atopic dermatitis

               -  Participation in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric J Duiverman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marianne L Brouwer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beatrix Children's Hospital, University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy. 2006 Jul;36(7):899-906.</citation>
    <PMID>16839405</PMID>
  </results_reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2005</study_first_posted>
  <last_update_submitted>September 26, 2006</last_update_submitted>
  <last_update_submitted_qc>September 26, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2006</last_update_posted>
  <keyword>Atopic Dermatitis</keyword>
  <keyword>SCORAD</keyword>
  <keyword>probiotics</keyword>
  <keyword>cytokines</keyword>
  <keyword>Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

